Skip to content

Insider · CIK 0001751744

Charles Benjamin Lee

director

Files at LITS (MEI Pharma, Inc.), BTCS (BTCS Inc.). First filing -, latest -.

In brief

Charles Benjamin Lee files SEC Form 4 as director at LITS (MEI Pharma, Inc.), and also at BTCS (BTCS Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Charles Benjamin Lee has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 9 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 31, 2026BTCS
BTCS Inc.
AGrant or award
Common Stock
+8,993--149,6204 d ago
Jun 30, 2026BTCS
BTCS Inc.
AGrant or award
Common Stock
+11,262--160,8824 d ago
Sep 30, 2026BTCS
BTCS Inc.
AGrant or award
Common Stock
+8,504--169,3864 d ago
Dec 31, 2025BTCS
BTCS Inc.
AGrant or award
Common Stock
+4,735--140,627Jan 5, 2026
Oct 3, 2025LITS
MEI Pharma, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+10,000$0.00$010,000Oct 6, 2025
Sep 30, 2025BTCS
BTCS Inc.
AGrant or award
Common Stock
+2,588--135,892Oct 2, 2025
Jun 30, 2025BTCS
BTCS Inc.
AGrant or award
Common Stock
+5,682--133,304Jul 2, 2025
Mar 31, 2025BTCS
BTCS Inc.
AGrant or award
Common Stock
+8,334$1.50$13k127,622Apr 2, 2025
Dec 31, 2024BTCS
BTCS Inc.
AGrant or award
Common Stock
+5,061--119,288Jan 2, 2025

Questions about Charles Benjamin Lee

Answered from the filings on this page, as of the latest one.

Is Charles Benjamin Lee buying or selling?

Charles Benjamin Lee has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Charles Benjamin Lee's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Charles Benjamin Lee has 0.

Where does Charles Benjamin Lee file Form 4?

Charles Benjamin Lee has filed Form 4 at LITS (MEI Pharma, Inc.); BTCS (BTCS Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Charles Benjamin Lee: insider trades and track record | InsiderTell